Tested Applications
| Positive IHC detected in | human placenta tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15944-1-AP targets CPZ in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8429 Product name: Recombinant human CPZ protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 303-652 aa of BC006393 Sequence: GAGYNGWTSGRQNAQNLDLNRNFPDLTSEYYRLAETRGARSDHIPIPQHYWWGKVAPETKAIMKWMQTIPFVLSASLHGGDLVVSYPFDFSKHPQEEKMFSPTPDEKMFKLLSRAYADVHPMMMDRSENRCGGNFLKRGSIINGADWYSFTGGMSDFNYLHTNCFEITVELGCVKFPPEEALYTLWQHNKESLLNFVETVHRGIKGVVTDKFGKPVKNARISVKGIRHDITTAPDGDYWRLLPPGIHIVIAQAPGYAKVIKKVIIPARMKRAGRVDFILQPLGMGPKNFIHGLRRTGPHDPLGGASSLGEATEPDPLRARRQPSADGSKPWWWSYFTSLSTHRPRWLLKY Predict reactive species |
| Full Name | carboxypeptidase Z |
| Calculated Molecular Weight | 652 aa, 74 kDa |
| Observed Molecular Weight | 70 kDa |
| GenBank Accession Number | BC006393 |
| Gene Symbol | CPZ |
| Gene ID (NCBI) | 8532 |
| RRID | AB_2878198 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q66K79 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CPZ antibody 15944-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CPZ polyclonal antibody (Cat# 15944-1-AP) has 3 total citations. These appear in American Journal of Surgical Pathology, Frontiers in Oncology, and Frontiers in Genetics. The research fields cover hepatocellular carcinoma versus intrahepatic cholangiocarcinoma differentiation, gastric cancer prognosis and immunomodulation, and DNA damage repair-based molecular subtypes in gastric cancer. Applications cited include IHC and WB in human samples.
| Species | Application | Title |
|---|---|---|
Am J Surg Pathol CPZ: A Highly Sensitive Diagnostic Biomarker for the Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma, Particularly in Poorly Differentiated Hepatocellular Carcinoma | ||
Front Oncol Novel perceptions of the involvement of CPZ in gastric cancer prognosis and immunomodulation. | ||
Front Genet Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer |
